Related Experiment Video
Updated: Apr 27, 2026
04:53
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
1.6K
Pulmonary embolism in chronic obstructive pulmonary disease: a population-based cohort study
Wei-Ji Chen1, Che-Chen Lin, Chang-Yi Lin
11From the Chest Division, Department of Internal Medicine, Mackay Memorial Hospital , Taipei , Taiwan.
COPD
|July 11, 2014
Summary
Patients with chronic obstructive pulmonary disease (COPD) have a four times higher incidence of pulmonary embolism (PE) compared to those without COPD. This risk increases with age and comorbidities, highlighting the need for PE consideration in COPD exacerbations.
Area of Science:
- Pulmonary Medicine
- Epidemiology
- Health Services Research
Background:
- Chronic obstructive pulmonary disease (COPD) is a significant global health concern.
- Pulmonary embolism (PE) is a potentially life-threatening condition.
- Understanding PE incidence in specific patient populations is crucial for public health.
Purpose of the Study:
- To determine the incidence of pulmonary embolism (PE) in patients diagnosed with chronic obstructive pulmonary disease (COPD) in Taiwan.
- To compare PE rates between COPD patients and a non-COPD control group.
- To identify risk factors associated with PE in the COPD population.
Main Methods:
- A retrospective population-based cohort study utilizing Taiwan's National Health Insurance Research Database (2000-2008).
- Inclusion of 355,878 patients with COPD and an equal number of non-COPD controls.
- Analysis of healthcare data to assess PE incidence and associated risk factors.
Main Results:
- The incidence of PE was approximately four times higher in the COPD cohort (12.31 per 10,000 person-years) compared to the non-COPD cohort (0.35 per 10,000 person-years).
- Younger COPD patients (20-59 years) exhibited a higher risk of PE (HR 4.64).
- COPD patients with comorbidities such as hypertension, coronary artery disease, cancer, or a history of operation had significantly increased PE risk.
Conclusions:
- While overall PE incidence in Taiwan is lower than in Western countries, COPD patients face a substantially higher prevalence.
- PE risk in COPD patients escalates with age and the presence of comorbidities.
- Clinicians should consider pulmonary embolism in the differential diagnosis for COPD exacerbations.
More Related Videos
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
3.0K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.0K
01:29Pulmonary Embolism I: Introduction
1.5K
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.5K
01:19Pulmonary Embolism I: Introduction
34
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
34
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
24
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet...
24
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
4.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K